← Open Payments lookup

MACDALINE SCOTT: Open Payments

NPI 1750040184 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,998 in 125 payments from 12 companies in 2025. Trend: 2023 $1,276 · 2024 $1,528 · 2025 $2,998

Food & beverage: $2,887Education: $111
CompanyPaymentsAmount
Alkermes, Inc.20$466
Teva Pharmaceuticals USA, Inc.17$465
Janssen Pharmaceuticals, Inc13$452
Otsuka America Pharmaceutical, Inc.15$309
Vanda Pharmaceuticals Inc.12$295
ABBVIE INC.17$278
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$203
Lundbeck LLC8$201
E.R. Squibb & Sons, L.L.C.6$144
Neurocrine BioSciences, Inc.5$115

Products named: INVEGA SUSTENNA, REXULTI, FANAPT, VRAYLAR, ARISTADA, UZEDY, LYBALVI, CAPLYTA.

Industry payments across PA — which companies pay providers there.